Development and Optimization of a Feeder Cell Free TIL Therapy Platform

被引：0
|
作者：
Haigh, Brandon [1 ]
Das, Rajat [1 ]
Gariepy, Cory [1 ]
Massala, Grace [1 ]
Abarca, Cristian [1 ]
Huang, Yuxiang [1 ]
Golovina, Tatiana [1 ]
机构：
[1] WuXi Adv Therapies, Wuxi, PA USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
927
引用
收藏
页码：451 / 451
页数：1
相关论文
共 50 条
  • [1] A Novel Feeder-Free Platform for Immune Cell Manufacturing
    Chen, Cheng-Tai
    Chen, Chien-An
    Chiang, Wen-Ting
    Chou, Nien-Tzu
    Lee, Chih-Hung
    Chiu, Su-Feng
    Lu, Ching-Fang
    MOLECULAR THERAPY, 2023, 31 (04) : 461 - 461
  • [2] Design, Development and Optimization of a Functional Mammalian Cell-Free Protein Synthesis Platform
    Heide, Chiara
    Buldum, Gizem
    Moya-Ramirez, Ignacio
    Ces, Oscar
    Kontoravdi, Cleo
    Polizzi, Karen M.
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 8
  • [3] Development of Cubosomes as a Cell-Free Biosensing Platform
    Fraser, Scott J.
    Dawson, Raymond M.
    Waddington, Lynne J.
    Muir, Ben W.
    Mulet, Xavier
    Hartley, Patrick G.
    Separovic, Frances
    Polyzos, Anastasios
    AUSTRALIAN JOURNAL OF CHEMISTRY, 2011, 64 (01) : 46 - 53
  • [4] Development of a Feeder-Cell-Free and Serum-Free Culture Method for Primary Natural Killer Cell Expansion
    Johnson, Christopher
    Frary, Eric
    Nazaire, Caroline
    Van Etten, Jamie
    Faulkner, Bora
    Joo, Sookyong
    Astry, Brian
    Hermanson, David
    Flynn, Kevin
    Jesuraj, Nithya
    Lomakin, Joseph
    MOLECULAR THERAPY, 2021, 29 (04) : 378 - 379
  • [5] NK-Xpander: Generation of a Feeder-Free NK Cell Expansion Medium for Cell Therapy
    Heipertz, Erica
    Hungler, Andrew
    Gill, Elise
    Vemuri, Mohan C.
    Kaur, Navjot
    MOLECULAR THERAPY, 2021, 29 (04) : 375 - 375
  • [6] Recent clinical researches and technological development in TIL therapy
    Matsueda, Satoko
    Chen, Lei
    Li, Hongmei
    Yao, Hui
    Yu, Fuli
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (11)
  • [7] KSQ-001EX: An engineered TIL therapy manufactured from a clinical-scale, feeder-free process for the treatment of solid tumor indications
    Lin, Sharon
    Martinez, Gustavo
    Forget, Marie-Andree
    Adlerz, Katrina
    Ghose, Mitali
    Williams, Leila
    Dunbar, Paul
    Thompson, Frank
    Sharp, Fiona
    Gannon, Hugh
    Calnan, Conor
    Yeri, Ashish
    Sangurdekar, Dipen
    Sakellariou-Thompson, Donald
    Fix, Samantha
    Griffith, Tamara
    Jafari, Ellie
    Zulovich, Jane
    Balasubramanian, Priya
    Willert, Erin
    Benson, Micah
    Bernatchez, Chantale
    Wong, Karrie Ka Wai
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Development and Characterization of a Feeder-free System to Study Goblet Cell Variant Basal Cells
    Tufenkjian, T. S.
    Blackburn, J. B.
    Liu, Y.
    Blackwell, T. S.
    Richmond, B. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [9] Antigen-specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapy
    Kelderman, Sander
    Heemskerk, Bianca
    Fanchi, Lorenzo
    Philips, Daisy
    Toebes, Mireille
    Kvistborg, Pia
    van Buuren, Marit M.
    van Rooij, Nienke
    Michels, Samira
    Germeroth, Lothar
    Haanen, John B. A. G.
    Schumacher, N. M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 (06) : 1351 - 1360
  • [10] Rejuvenation of tumor-infiltrating lymphocytes (TIL): A novel strategy to revitalize TIL antitumor function for cell therapy
    Vizcardo, Raul
    Huang, Yin
    Fioravanti, Jessica
    Maeda, Takuya
    Tamaoki, Naritaka
    Yamazaki, Yasuhiro
    Kutlu, Burak
    Bahl, Kriti
    Wang, Biao
    Zhong, Zheng
    Potluri, Shobha
    Restifo, Nicholas P.
    Lee, Gary
    CANCER RESEARCH, 2024, 84 (06)
12345